Cryptococcus is the major pathogen that causes fungal meningitis. In the People's Republic of China, especially in the Southwest area, cryptococcal meningitis (CM) in HIVuninfected patients is more common than in HIV-infected patients. We compared clinical features and laboratory data pertaining to CM in patients with different immunological statuses. Demographic data, clinical manifestations, and laboratory data from inpatients in West China
Introduction
Cryptococcus is an encapsulated basidiomycetous yeast and the major pathogen that causes the fungal meningitis. Cryptococcal meningitis (CM) is associated with significant morbidity and mortality. Globally, among persons living with human immunodeficiency virus (HIV), approximately 957,900 cases (range, 371,700-1,544,000) of CM occur each year, resulting in 624,700 deaths (range, 125,000-1,124,900) by 3 months after infection. 1 Previous studies from other regions have shown that the majority of CM patients are HIV-infected. A study using the State Inpatient Databases (SID) data sets from 1997 to 2009 show that 79.4% of CM cases were associated with HIV in the United States. 2 In Brazil, in a retrospective study from 2000
to 2005, 95% of CM patients were HIV-infected. 3 In the People's Republic of China, however, it occurs most commonly in HIV-uninfected patients, and the proportion of non-HIV patient cases was reported to be between 58% and 73.6%. [4] [5] [6] [7] The epidemiological characteristics of CM in Southwest People's Republic of China are unknown. Due to their different immune statuses, we wondered if the clinical features or laboratory data between HIVinfected and HIV-uninfected patients differed. We also attempted to identify earlier diagnostic clues of CM in patients with different immune status by comparing clinical features and laboratory data of HIV-infected and HIVuninfected patients with CM who were admitted to West China Hospital Sichuan University from 2009 to 2014.
Materials and methods
All CM patients aged 16 years or over admitted to West China Hospital Sichuan University from June 2009 to June 2014 were enrolled in this study. Outpatient and emergency patients were excluded because of the lack of clinical data. A total of 85 CM had isolated Cryptococcus species from cerebrospinal fluid (CSF) culture or positive CSF Jincheng ink, and consistent clinical features of meningitis. All enrolled patients were grouped according to HIV status. Age, sex, underlying diseases, presenting clinical symptoms, and laboratory data of these patients were retrospectively reviewed.
HIV infection was detected by positive electrochemiluminescence immunoassay method (Roche Diagnostics GmbH, Mannheim, Germany) and/or positive enzymelinked immunosorbent assay (Zhuhai Livzon Diagnostics Inc., Guangdong, People's Republic of China), and confirmed by Western blot (MP Biomedicals Asia Pacific Pte Ltd., 2 Pioneer Place, Singapore). All isolates were identified using an API 20C system (BioMerieus, France) and Matrix-assisted laser desorption ionization-time of flight mass spectrometry (Bruker, Germany). 8 Blood analyses (CD4 count, CD4/CD8, HIV viral load, complete blood cell counts, differential counts, and albumin) and CSF tests (number of leukocytes, protein, chloridum, glucose, albumin, Jincheng ink [Yin Teli Stationery Co, Sichuan, People's Republic of China], and culture) were processed in accordance with standard protocols. The ratio of albumin in CSF to albumin in serum (Q ALB ) protein and intrathecal immunoglobulin G (IgG) synthesis were calculated. The accuracy of all tests was guaranteed by taking part in proficiency testing of the College of American Pathologists. Reports of chest film or computed tomography (CT) or magnetic resonance imaging (MRI) were analyzed. We followed the principles outlined in the Declaration of Helsinki to perform the experiments. Ethical approval was given by West China Hospital Sichuan University Biomedical Ethics Committee with the following approval number: 203 (2015 
Results
Eighty-four Cryptococcus neoformans and one Cryptococcus gattii strain were identified in our study.
Comparisons of demographic and clinical features in the HIV-infected and HIV-uninfected groups are shown in Table 1 . In total, 85 patients with CM were identified over the 5-year span. Among them, 53 (62.4%) were HIV-uninfected patients. There were no significant differences in ages between the two groups (38.56 vs. 42.03, P = .112). CD4 count was performed in 27 HIVinfected patients and HIV viral load was detected in 14 HIV-infected patients. The mean of HIV viral load was 5.25 log10copies/ml (range: 3∼6.58 log10copies/ml). All of the patients in the HIV-infected group had CD4 counts<200/mm 3 indicated that 46(88.5%) HIV-infected with CM patients and 29 (93.5%) HIV-uninfected with CM patients were positive. CM occurred in males (90% vs. 67.9%, P = .017) more frequently in the HIV-infected group. Conversely, HIV-uninfected patients more frequently had at least one underlying disease (37.7% vs. 15.6%, P = .025). Autoimmune diseases were the most frequently recorded underlying diseases, but there were no significant differences in underlying diseases between the two groups. Overall, 20 patients (37.7%) had at least one predisposing factor, and 6 patients (11.3%) in the HIV-uninfected CM group had more than one predisposing factor. The median time of hospital stay among HIV-uninfected individuals was longer than HIV-infected individuals (29.5d vs. 10.5d, respectively; P < .001), but the rate of in-hospital mortality in HIV-associated cryptococcal infection was higher (25% vs. 3.7%, P = .005).
Presentations are shown in Table 1 ; most of the patients were acute onset. The main symptoms of the CM patients were headache, vomiting, and fever, but there were no significant differences in initial symptoms of the two groups. In the patients with recorded open pressure during lumbar puncture, increased pressure (200 mm H 2 O) was common in both groups. Besides of headache and vomiting, some symptoms may be related to increased intracranial pressure, such as dizziness, abnormal vision, and meningeal irritation of the two groups.
Compared with the HIV-infected patients, HIVuninfected patients had higher numeration of leukocyte in blood, higher numeration of leukocyte, and protein in the CSF. Although there were no significant differences in CSF glucose of the two groups, more proportion of HIVuninfected patients have a tendency to decrease CSF glucose. More HIV-uninfected patients with increased QALB, at the same time IgG synthesis in the HIV-uninfected group were significantly increased (median, 52.81 vs. 6.9, P < .001). These results are shown in Table 1 .
Brain images were performed in 47 HIV-uninfected patients and 24 HIV-infected patients. 18 (38.3%) HIV-uninfected patients and 11(45.8%) HIV-infected patients had normal image findings. The presentation of meningeal enhancement was indicated more frequently in the HIV-infected group (23.4% vs. 4.2%, P = .049). Other brain image findings included infarct, hydrocephalus, cystic, nodule, and demyelination. But there were no significant differences in other presentations between the two groups. Chest images were performed in 39 HIV-uninfected patients and 20 HIV-infected patients. The most common presentation was mass or nodule lesion in both of group.
Discussion
Research on cryptococcosis has a 120-year history since its first description in 1894. 9 In the 1950 s, cryptococcosis was reported in less than 500 patients globally, 10 4, 6, 7 Compared with other ethnic studies, 2, 3, 12 immunocompetent hosts in the Chinese ethnic population might be more susceptible to cryptococcal infections than other ethnic groups. Besides HIV infection, as shown in Table 1 , non HIV-associated cryptococcal infection patients had other documented underlying diseases, including hypertension, diabetes mellitus, hematology and oncology, autoimmune diseases, renal diseases, solid organ transplants, opportunistic infections, and hepatobiliary diseases. This is different from Liao et al.'s report that indicated that non HIV-associated cryptococcal infection patients had a significantly higher proportion of predisposing factors. However, HIV-uninfected patients tended to have at least one underlying disease. This may be the reason why HIV-uninfected individuals had longer hospital stays than HIV-infected individuals in our study. Also different from the report by Liao et al., 4 our study found that CM in HIV-infected patients was associated with significant in-hospital mortality compared with HIV-uninfected patients. Only one case of C. gattii strain was found in our study. This case was a non HIV-associated cryptococcal infection. The patient was a middle-aged man from a city of Sichuan Province. Clinical performance of this patient: acute onset, headache, vomiting, meningeal irritation, and epileptic seizures. The patient had no underlying disease and had normal brain image findings. No significant differences in demographic, characteristics and laboratory data with other HIV-uninfected patients. This is consistent with previous reports C. gattii causes disease mainly in immunocompetent individuals. 13, 14 After treatment of amphotericin B and flucytosine for 11 months, his condition improved and discharged. The two groups of CM patients commonly presented with acute onset and in our study there was no significant difference in duration of initial symptoms between groups, which is in agreement with earlier reports, 4, 15 The main initial symptoms of CM, such as headache, fever, and vomiting, are similar to tuberculous meningitis and bacterial meningitis. [16] [17] [18] Therefore, clinical signs are of no value for differentiating between HIV-uninfected and HIV-infected CM patients, or between CM and other types of meningitis by reason of low sensitivity and specificity of diagnoses. At the same time, compared to HIV-uninfected patients, lower CSF leukocytes and protein and decreased local synthesis of IgG level in the central nervous system reflected the lowered immune response in HIV-infected patients. These characteristics should be reviewed in order to avoid misdiagnosis. Five patients presented cough in our study. Only two patients were performed sputum culture, and results were negative. Chest imagings were performed in four patients. Two patients had mass or nodule; one patient was proved to have cavity. There is no direct evidence that those patients have pulmonary involvement during stay of the hospital.
Our results revealed some laboratory data differences between HIV-infected and HIV-uninfected patients with CM. For instance, HIV-uninfected patients had higher numbers of leukocytes in the blood, and more leukocyte and protein in the CSF, which is consistent with prior reports showing that these features are almost always abnormal in non HIV-associated cryptococcal infection, while HIVassociated cryptococcal infection only show mildly abnormal values. 4 Moreover, intrathecal IgG synthesis in the HIV-uninfected group was significantly higher. A greater inflammation response in the blood and CNS of HIVuninfected patients might play an important role in eliminating the pathogen and might contribute to a better outcome. The higher proportion of HIV-uninfected patients were detected meningeal enhancement is compatible with HIV-infected patients. This may be performance of aggressive inflammatory response on images.
The blood-brain barrier is the passage through the capillary wall. Many neurological diseases exhibit blood-CSF barrier (BCB) dysfunction accompanied with increased protein concentrations in the CSF. Levels of CSF albumin are determined by blood levels, blood-CSF barrier permeability, and CSF turnover. 19 The ratio of albumin in the Q ALB has been widely accepted as an index to appraise BCB function. Tang et al.'s study showed that Q ALB in the tuberculous meningitis recovery group was significantly higher than in the tuberculous meningitis progression group, which may be due to the fact that the treatment effect was greatly weakened because drug was hindered by the BCB. 16 Other studies have also shown that the antibacterial effect is correlated with BCB permeability in bacterial meningitis. 20 For
CM treatment, some research shows that intrathecal administration of amphotericin B has been proven to be an effective adjunctive treatment for cryptococcosis in the People's Republic of China, as shown by Yao et al. 21 and Yuchong et al. 22 Intrathecal AmB injection is the most important therapy to control cryptococcal CNS disease. However, intrathecal injections impart a higher risk of toxic effects or severe complications, such as urinary retention, subarachnoid adhesions, irritated cerebrospinal meningitis, convulsions, and even coma. 20 A comprehensive analysis designed to achieve a better prognosis via treatment of CM may need to consider the permeability of the BCB. Our results show that HIV-uninfected patients have more serious BCB dysfunction; however, the rate of in-hospital mortality of HIVrelated CM patients was higher. We hypothesize that HIVuninfected CM patients have more severe BCB dysfunction, and this results in better medication efficacy. Therefore, we believe that different drug dosages, course of treatment, and administration routes should be used in the two groups of patients, 23 taking into consideration the different BCB state. Moreover, we may be able to utilize the permeability of the BCB to determine whether intrathecal injection should be implemented to achieve a better outcome and avoid complications. These theories will be addressed in future studies. There are some limitations in our study. First, our study was a retrospective research using patient medical records and laboratory data. There must be data loss and misclassification in this kind of study. Second, lack of data to compare cryptococcal antigen titer between HIV-infected and HIV-uninfected patients with CM. Third, no data to compare the groups of patients concerning the antifungal therapy and duration of the treatment. In our further studies, latex agglutination will be used to detected cerebrospinal fluid antigen to investigate the connection of cryptococcal antigen titer and mortality and cohort study will be design to compare the groups of patients concerning the antifungal therapy and duration of the treatment. Fourth, only one case of C. gattii strain was found in our study. In the further study, we will compare the difference immune status between the two groups of patients with C. gattii species complex versus C. neoformans species complex infections after collecting more cases of C. gattii species complex infections.
In summary, clinical signs are similar between HIVuninfected and HIV-infected CM patients, fewer leukocytes and protein was detected in the CSF and lower local synthesis of IgG in the central nervous system in HIV-infected patients, which reflects their diminished immune response. These characteristics should be noted in order to avoid misdiagnosis. Meningeal enhancement of brain images and intrathecal IgG synthesis in the HIV-uninfected group was significantly higher, that may be performance of aggressive inflammatory response and might contribute to a better outcome. The permeability of the BCB may be considered in the treatment of cryptococcal meningitis to achieve a better prognosis.
